[go: up one dir, main page]

AR133076A1 - Compuestos novedosos - Google Patents

Compuestos novedosos

Info

Publication number
AR133076A1
AR133076A1 ARP240101641A ARP240101641A AR133076A1 AR 133076 A1 AR133076 A1 AR 133076A1 AR P240101641 A ARP240101641 A AR P240101641A AR P240101641 A ARP240101641 A AR P240101641A AR 133076 A1 AR133076 A1 AR 133076A1
Authority
AR
Argentina
Prior art keywords
novel compounds
compounds
novel
methods
general formula
Prior art date
Application number
ARP240101641A
Other languages
English (en)
Inventor
David Bon
Lea Aurelie Bouche
Emma Hargrave
Georg Jaeschke
Heather Jennifer Johnston
Stefanie Katharina Mesch
Christian Schnider
Andreas Michael Tosstorff
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR133076A1 publication Critical patent/AR133076A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a compuestos novedosos que tienen la fórmula general (1) en donde A, R¹, R² y n son como se describen en la presente, composición que incluye los compuestos y métodos para usar los compuestos.
ARP240101641A 2023-06-29 2024-06-27 Compuestos novedosos AR133076A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP23182238 2023-06-29

Publications (1)

Publication Number Publication Date
AR133076A1 true AR133076A1 (es) 2025-08-27

Family

ID=87060304

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240101641A AR133076A1 (es) 2023-06-29 2024-06-27 Compuestos novedosos

Country Status (7)

Country Link
CN (1) CN121368590A (es)
AR (1) AR133076A1 (es)
AU (1) AU2024307670A1 (es)
CO (1) CO2025019059A2 (es)
IL (1) IL324489A (es)
TW (1) TW202517626A (es)
WO (1) WO2025003288A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024517917A (ja) 2021-05-12 2024-04-23 エフ． ホフマン－ラ ロシュ アーゲー Ｎｌｒｐ３阻害剤

Also Published As

Publication number Publication date
WO2025003288A1 (en) 2025-01-02
IL324489A (en) 2026-01-01
CO2025019059A2 (es) 2026-01-23
AU2024307670A1 (en) 2025-11-20
TW202517626A (zh) 2025-05-01
CN121368590A (zh) 2026-01-20

Similar Documents

Publication Publication Date Title
AR131282A1 (es) Compuestos novedosos
AR131006A1 (es) Compuestos novedosos
CL2021001330A1 (es) Nuevos compuestos heterocíclicos
AR130984A1 (es) Compuestos novedosos
CO2023016204A2 (es) Inhibidores de nlrp3
CL2023003154A1 (es) Compuestos heterocíclicos
CO2023004195A2 (es) Compuestos heterocíclicos
CL2022001091A1 (es) Dihidrobenzofurano e inden analogos como inhibidores de sarcómero cardíaco (divisional de solicitud 202001871).
CO2023016212A2 (es) Derivados de triazina y su uso en el tratamiento del cáncer
AR131278A1 (es) Compuestos novedosos
AR132377A1 (es) Compuestos novedosos
CO2023010212A2 (es) Derivados novedosos de pirimidin-2-il sulfonamida
CO2022002000A2 (es) Nuevos inhibidores heterocíclicos de monoacilglicerol lipasa (magl)
CL2022000802A1 (es) Compuestos heterocíclicos de arilmetileno como bloqueadores del canal shaker de potasio kv1.3
AR132456A1 (es) Compuestos novedosos
CL2022000019A1 (es) Nuevos compuestos heterocíclicos
CO2022002336A2 (es) Compuestos heterocíclicos
UY38941A (es) Nuevas sulfiliminas o sulfoximinas que contienen compuestos heterocíclicos fungicidas
CO2025003256A2 (es) Derivados novedosos deuterados de pirimidin-2-il sulfonamida
CR20240203A (es) Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2
CL2025000126A1 (es) Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina.
CL2025000125A1 (es) Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina.
AR133076A1 (es) Compuestos novedosos
AR133375A1 (es) Compuestos novedosos
MX2023015490A (es) Inhibidores de las transglutaminasas.